J Korean Thyroid Assoc.  2012 Nov;5(2):94-98. 10.11106/jkta.2012.5.2.94.

Thyroid Dysfunction in the Elderly

• Kim JH

• KMID: 2095096
• DOI: http://doi.org/10.11106/jkta.2012.5.2.94

Abstract

The normal aging process is accompanied by changes in the appearance of the thyroid gland, both macroscopic and microscopic. The changes in thyroid function attributable solely to aging are subtle and of questionable clinical significance. Instead, there is an increase in thyroid disease with increasing age. It can be challenging to accurately diagnose thyroid dysfunction in the elderly, since presenting symptoms may be atypical, and other co-morbid conditions may obscure the diagnosis. For these reasons, it is always important to consider the possibility of thyroid disease in the elderly. The lack of consensus about what constitutes a normal thyroid stimulating hormone (TSH) level for an elderly patient in turn leads to disparate recommendations on the threshold for initiating therapy for sub-clinical thyroid dysfunction and the target TSH level during therapy. We review the existing data on the prevalence, causes, clinical manifestations, diagnostic issues, and treatment of thyroid dysfunction in the elderly.

Keyword

Thyroid dysfunction; The elderly

MeSH Terms

Aged
Aging
Consensus
Humans
Prevalence
Thyroid Diseases
Thyroid Gland
Thyrotropin
Thyrotropin

Reference

1. Hershman JM, Hassani S, Samuels MH. Hazard WR, editor. Thyroid diseases. Principles of geriatric medicine and gerontology. 2008. 6th ed. New York, NY: McGraw-Hill;1287–1304.

2. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998. 8(9):803–813.

3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000. 160(4):526–534.

4. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995. 43(1):55–68.

5. Brent GA. Samuels MH, editor. Thyroid function testing. Assessing thyroid function in the elderly. 2010. . New York, NY: Springer;235–250.

6. Doucet J, Trivalle C, Chassagne P, Perol MB, Vuillermet P, Manchon ND, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994. 42(9):984–986.

7. Feldt-Rasmussen U. Treatment of hypothyroidism in elderly patients and in patients with cardiac disease. Thyroid. 2007. 17(7):619–624.

8. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008. 29(1):76–131.

9. Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med. 2008. 168(14):1514–1520.

10. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid. 2007. 17(7):625–630.

11. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008. 93(8):2998–3007.

12. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004. 292(21):2591–2599.

13. Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004. 89(10):4890–4897.

14. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf). 1977. 7(6):481–493.

15. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002. 87(2):489–499.

16. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab. 2005. 90(12):6403–6409.

17. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012. 379(9821):1142–1154.

18. Tibaldi JM, Barzel US, Albin J, Surks M. Thyrotoxicosis in the very old. Am J Med. 1986. 81(4):619–622.

19. Cho BY. Cho BY, editor. Thyroid disease in elderly. Clinical thyroidology. 2010. 3rd ed. Seoul: Korea Medical Book Publishing Company;765–770.

20. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008. 148(11):832–845.

21. Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid. 2002. 12(6):501–503.

22. Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol. 2008. 159(3):329–341.

23. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001. 134(7):561–568.

24. Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, Chen Z, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010. 170(21):1876–1883.

25. Wexler JA, Sharretts J. Thyroid and bone. Endocrinol Metab Clin North Am. 2007. 36(3):673–705.

26. Diez JJ, Iglesias P. An analysis of the natural course of subclinical hyperthyroidism. Am J Med Sci. 2009. 337(4):225–232.

27. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011. 21(6):593–646.